- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: dabrafenib and trametinib
Total 269809 results
-
Universitair Ziekenhuis BrusselCompleted
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsAvailable
-
Novartis PharmaceuticalsCompletedMalignant MelanomaPortugal
-
Novartis PharmaceuticalsRecruitingBRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid TumorJapan
-
Leiden University Medical CenterNovartisRecruitingAnaplastic Thyroid CancerNetherlands
-
EuMelaReg gGmbHActive, not recruiting
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | BRAF V600 Mutation | MET Exon 14 MutationChina
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsRecruiting
-
Eva Marie Erfurth, MD, PhDNovartisRecruiting
-
Poitiers University HospitalCompletedUnresecable Stage IIIc or IV MelanomaFrance
-
Novartis PharmaceuticalsAvailable
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Haukeland University HospitalBerGenBio ASAActive, not recruiting
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
Novartis PharmaceuticalsRecruitingGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditionsUnited States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel, Brazil
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
GlaxoSmithKlineTerminatedMelanoma and Brain MetastasesUnited States, Australia
-
National University Hospital, SingaporeSingapore General HospitalUnknown
-
University Hospital, EssenRecruitingMetastatic Thyroid CancerGermany
-
Novartis PharmaceuticalsRecruitingDifferentiated Thyroid CancerChina, Korea, Republic of, Taiwan, India, Malaysia, Turkey, Canada, Vietnam, Argentina, Brazil, Mexico, United States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma (Locally Advanced) | Stage IIC Melanoma (Locally Advanced) | Stage IV Melanoma (Limited, Resectable)United States
-
Olivia Newton-John Cancer Research InstituteThe Alfred; Austin Health; Peter MacCallum Cancer Centre, Australia; Royal Brisbane... and other collaboratorsRecruiting
-
Fondazione Melanoma OnlusWithdrawn
-
Bhavana KondaNational Comprehensive Cancer NetworkActive, not recruitingInsular Thyroid Cancer | Recurrent Thyroid Cancer | Papillary Thyroid Cancer | Follicular Thyroid CancerUnited States
-
TriHealth Inc.TriHealth Cancer Institute; TriHealth Surgical Institute; TriHealth Ultrasound... and other collaboratorsWithdrawnMelanoma (Skin) | Tumor Skin | BRAF Gene Mutation | Melanoma Stage IIIb-IVM1a | Metastasis SkinUnited States
-
Novartis PharmaceuticalsCompleted
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | BRAF V600EKorea, Republic of
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNSCLC | Advanced Cancer | Stage IV NSCLC | BRAF V600E Mutation | Stage IIIB NSCLC
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Human Genome Research Institute (NHGRI)CompletedBRAF V600E MutationUnited States
-
Novartis PharmaceuticalsCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
GlaxoSmithKlineTerminated
-
Novartis PharmaceuticalsCompletedMelanoma | CancerTaiwan, Thailand, China, Hong Kong, Korea, Republic of
-
GlaxoSmithKlineNo longer available
-
Se Jun ParkRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingStudy of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid CancerThyroid Cancer | Anaplastic Thyroid Cancer | BRAF Gene Mutation | BRAF Mutation-Related TumorsUnited States
-
GlaxoSmithKlineWithdrawn
-
National Cancer Institute (NCI)WithdrawnDabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 MutationsErdheim-Chester DiseaseUnited States
-
Massachusetts General HospitalNovartis; Barbara Ann Karmanos Cancer Institute; Multiple Myeloma Research ConsortiumRecruitingA Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple MyelomaMultiple MyelomaUnited States
-
MelanomaPRO, RussiaNovartisRecruitingMelanoma | Melanoma Stage IV | Melanoma Stage IIIRussian Federation
-
Novartis PharmaceuticalsWithdrawn
-
Melanoma Institute AustraliaActive, not recruiting
-
Canadian Cancer Trials GroupNovartisTerminatedMelanoma | Brain MetastasesCanada
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Oxford; National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS TrustCompleted
-
M.D. Anderson Cancer CenterGlaxoSmithKline; Cancer Prevention Research Institute of TexasCompleted